Open Access Review Article Article ID: JCMC-7-254

    ACEi to ARNi: “The Switch” An Evidence Based Review

    Yusuf Hassan*, Zahra Hassan, Ayesha Hassan, Asad A Saleem and Waqas Ahmed

    Heart failure affects approximately 6.5 million adults in the United States, and the cost to healthcare system is tremendous [1]. Effective treatment for this very important disease is constantly evolving. The most significant change in the recent past has been the development of ARNI (Sacubitril/ Valsartan) for treatment of heart failure [2].


    Published on: Oct 30, 2020 Pages: 288-292

    Full Text PDF Full Text HTML DOI: 10.17352/2455-2976.000154
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on JCMC

    Help ? Google Reviews 11